| Title |
Ritonavir: An Extraordinary Example of Conformational Polymorphism
|
|---|---|
| Published in |
Pharmaceutical Research, June 2001
|
| DOI | 10.1023/a:1011052932607 |
| Pubmed ID | |
| Authors |
John Bauer, Stephen Spanton, Rodger Henry, John Quick, Walter Dziki, William Porter, John Morris |
| Abstract |
In the summer of 1998, Norvir semi-solid capsules supplies were threatened as a result of a new much less soluble crystal form of ritonavir. This report provides characterization of the two polymorphs and the structures and hydrogen bonding network for each form. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 905 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 8 | <1% |
| Brazil | 3 | <1% |
| Ireland | 2 | <1% |
| United States | 2 | <1% |
| Russia | 2 | <1% |
| Germany | 2 | <1% |
| Hong Kong | 1 | <1% |
| Canada | 1 | <1% |
| France | 1 | <1% |
| Other | 4 | <1% |
| Unknown | 879 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 205 | 23% |
| Student > Master | 121 | 13% |
| Student > Bachelor | 109 | 12% |
| Researcher | 107 | 12% |
| Student > Doctoral Student | 41 | 5% |
| Other | 128 | 14% |
| Unknown | 194 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 320 | 35% |
| Pharmacology, Toxicology and Pharmaceutical Science | 127 | 14% |
| Chemical Engineering | 47 | 5% |
| Materials Science | 39 | 4% |
| Engineering | 33 | 4% |
| Other | 117 | 13% |
| Unknown | 222 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2023.
All research outputs
#3,056,223
of 26,017,215 outputs
Outputs from Pharmaceutical Research
#192
of 3,104 outputs
Outputs of similar age
#3,306
of 43,483 outputs
Outputs of similar age from Pharmaceutical Research
#1
of 14 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,104 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 43,483 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.